for patients with altered renal function see the patients with impaired renal function subsection levaquin birth control. the plasma concentration profile of levofloxacin after i levaquin dose. v. bacterial infection: the pharmacokinetics of levofloxacin in patients with community-acquired bacterial infections are comparable to those observed in healthy subjects. to reduce the development of drug-resistant bacteria and maintain the effectiveness of levaquin package insert® (levofloxacin) and other antibacterial drugs, levaquin package insert should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria effects levaquin side. v. levaquin package insert tablets/injection and oral solution are indicated for the treatment of adults (?18 years of age) with mild, moderate, and severe infections caused by susceptible strains of the designated microorganisms in the conditions listed below leva levaquin pak. levofloxacin is in a class of antibiotics called fluoroquinolones alcohol interaction levaquin. do not use any medicine to stop the diarrhea unless your doctor has told you to. levofloxacin is not recommended for use in lactating women since levofloxacin causes joint and bone deformities in juvenile animals of several species. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy 500mg levaquin. appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing the infection and to determine their susceptibility to levofloxacin levaquin shelf life. steady-state is reached within 48 hours following a 500 mg once-daily regimen. lung tissue concentrations were generally 2- to 5-fold higher than plasma concentrations and ranged from approximately 2. taking non-steroidal anti-inflammatory drugs (nsaids) with levofloxacin may increase the risk of cns stimulation, resulting in over-excitation. the safety and efficacy of levofloxacin in pediatric patients, adolescents (under 18), pregnant women, and nursing mothers have not been established. continue to take levofloxacin even if you feel well. distribution: the mean volume of distribution of levofloxacin generally ranges from 89 to 112 l after single and multiple 500 mg doses, indicating widespread distribution into body tissues. tendon ruptures that required surgical repair or resulted in prolonged disability have been reported in patients receiving quinolones, including levofloxacin, during and after therapy alcohol drinking levaquin medication. levofloxacin is not recommended for use in pregnant women since levofloxacin causes joint and bone deformities in juvenile animals of several species. due to the limited extent of levofloxacin metabolism, the pharmacokinetics of levofloxacin are not expected to be affected by hepatic impairment levaquin pregnancy. levaquin package insert can cause side effects that may impair your thinking or reactions. minerals with 2 or 3 positive charges, called divalent or trivalent ions, respectively, can attach to levofloxacin and other fluoroquinolones and prevent their absorption from the intestine into the blood. levofloxacin also penetrates into lung tissues. factors influencing the pharmacokinetics: special populations: geriatrics: there are no significant differences in levofloxacin pharmacokinetics between young and elderly subjects when the subjects' differences in creatinine clearance are taken into consideration. the peak and trough plasma concentrations attained following multiple once daily i 500mg antibiotic levaquin levofloxacin. the mechanism of action of levofloxacin and other quinolone antibacterials involves inhibition of dna gyrase (bacterial topoisomerase ii), an enzyme required for dna replication, transcription, repair and recombination levaquin antibiotic. levofloxacin is contraindicated in persons with a history of hypersensitivity to levofloxacin, quinolone antimicrobial agents, or any other components of this product. the mean terminal plasma elimination half-life of levofloxacin ranges from approximately 6 to 8 hours following single or multiple doses of levofloxacin given orally or i levaquin strep throat. 8 µg/ml respectively. therefore, levofloxacin can be administered without regard to food. levofloxacin is the l-isomer of the racemate, ofloxacin, a quinolone antibacterial agent. peak plasma concentrations are usually attained 1 to 2 hours after oral dosing 750 levaquin mg. taking these other medicines too close to your dose of levaquin package insert can make the antibiotic much less effective. 7 µg/ml and 0. fluoroquinolones, including levofloxacin, differ in chemical structure and mode of action from other classes of antimicrobial agents such as b-lactam antibiotics, aminoglycosides, and macrolides. levaquin package insert injection is indicated when intravenous administration offers a route of administration advantageous to the patient (e levaquin side effect. the most frequently reported side events are nausea or vomiting (1 out of every 12 persons), diarrhea (1 out 20), headache (1 out 20), and constipation (1 out of 30). v.